In addition, the pharmacology with the active parts was mainly uncharacterized, and affirmation of SCB use was hindered by a lack of identified biomarkers. These knowledge gaps prompted experts throughout several disciplines to promptly (1) observe, discover and quantify with chromatography/mass spectrometry the at any time-changing contents of her